Non-progressive placental abruption in incomplete pregnancy: aspects of diagnostic-therapeutic tactics

В. І. Пирогова, З. В. Сміх

Abstract


Questions of accompany pregnancy with non-progressive partial placental abruption in incomplete pregnancy remain relevant for a long time and concern, in particular, the safety and efficacy of the use of hemostatic agents.
A study involving 127 patients with placental insufficiency, who were hospitalized at 22–26 weeks of gestation with signs of placental abruption was performed.
Patients were randomized into two groups: 32 pregnant of main group received tranexamic acid (drug Tranexam) as a hemostatic therapy, 15 patients of comparison group received etamsylatum.
As a result, it was found that the drug Tranexam in average daily doses (750–1 000 mg/day) for treatment duration of 5–7 days has more pronounced hemostatic effect, does not cause side effects, thus successfully maintain the pregnancy


Keywords


pregnancy; placental abruption; hemostasis; tranexamic acid

References


Bilyk, N.M. “Pregnancy in women with risk of premature detachment of the placenta at prophylactic treatment.” Women’s Health, 1(2007):94-96.

Demina, T.N., Chaika, K.V. “Determination of D-dimer to predict thrombotic complications in pregnant and postpartum women at risk group.” Medical and Social Problems of the Family, 11(4) (2006):24-32.

Serov, V.N., Sukhikh, G.T. “Clinical recommendations. Obstetrics and gynecology.” M: GEOTAR -Media (2014):488-497.

Murashko, A.V., Kravchenko, N.F., Gribanova, N.D. “Hemorheological disorders in hypertension during pregnancy and their possible correction.” Gynecology, 9(5) (2007):17-19.

Sidelnikova, V.M., Kiryushchenkov, P.A.

Haemostasis and pregnancy. M.: Triada-X (2004).

Tingborn, L. “Inhibitors of fibrinolysis in the treatment of hemorrhagic disorders.” Hemophilia Treatment, 42 (2007).

Shevchenko, Y.L., et al. “Effect of blood saving of tranexamic acid.” Farmateka, 16(2008):17-25.

De Lange, N.M., Lancé, M.D., de Groot, R., et al. “Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage.” Obstet. Gynecol. Surv., 67(7) (2012):426-435.

Peitsidis, P., Kadir, R.A. “Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum.” Expert Opin. Pharmacother, 12(4) (2011):503-516.

Rasmussen, S., Irgens, L.M. “Occurrence of placental abruption in relatives.” BJOG, 116(5) (2009):693.

Su, L.L., Chong, Y.S. “Massive obstetric haemorrhage with disseminated intravascular coagulopathy.” Best Pract. Res. Clin. Obstet. Gynaecol, 26(1) (2012):77-90.

Tower, C.L., Regan, L. “Intrauterine haematomas in a recurrent miscarriage population.” Hum. Reprod, 16(9) (2001):2005-2007.

Van Oppenraaij, R.H., Jauniaux, E., Christiansen, O.B., et al. “Predicting adverse obstetric outcome after early pregnancy events and complications: a review.” Hum. Reprod. Update, 15(4) (2009):409-421.


GOST Style Citations


1. Білик, Н.М.
Перебіг вагітності у жінок групи ризику по виникненню передчасного відшарування
плаценти при профілактичному лікуванні / Н.М. Білик // Здоровье женщины. – 2007. –
№ 1. – С. 94–96.

2. Демина,Т.Н. Определение D-димера с целью прогнозирования тромботических осложнений у беременных и родильниц группы риска / Т.Н. Демина, К.В. Чайка // Медико-социальные проблемы семьи. – 2006. – Т. 11, № 4. – С. 24–32.

3. Серов, В.Н. Клинические рекомендации. Акушерство и гинекология / В.Н. Серов, Г.Т. Сухих // М.: ГЕОТАР-Медиа, 2014. – С. 488–497. 

4. Мурашко, А. В.
Гемореологические расстройства при гипертензии во время беременности и возможности
их коррекции / А.В. Мурашко, Н.Ф. Кравченко, Н.Д. Грибанова // Гинекология. – 2007.– Т. 9,
№ 5. – С. 17–19.

5. Сидельникова, В.М. Гемостаз и беременность / В.М. Сидельникова, П.А. Кирющенков // М.: Триада-Х., 2004.

6. Тингборн, Л. Ингибиторы фибринолиза при лечении геморрагических расстройств / Л. Тингборн // Лечение гемофилии. – 2007. – № 42.

7. Шевченко, Ю.Л. Кровесберегающий эффект транексамовой кислоты / Ю.Л. Шевченко и др. // Фарматека. – 2008. – № 16. – С. 17–25.

8. De Lange, N.M., Lancé, M.D., de Groot, R., et al. “Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage.” Obstet. Gynecol. Surv., 67(7) (2012):426-435.

9. Peitsidis, P., Kadir, R.A. “Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum.” Expert Opin. Pharmacother, 12(4) (2011):503-516.

10. Rasmussen, S., Irgens, L.M. “Occurrence of placental abruption in relatives.” BJOG, 116(5) (2009):693.

11. Su, L.L., Chong, Y.S. “Massive obstetric haemorrhage with disseminated intravascular coagulopathy.” Best Pract. Res. Clin. Obstet. Gynaecol, 26(1) (2012):77-90.

12. Tower, C.L., Regan, L. “Intrauterine haematomas in a recurrent miscarriage population.” Hum. Reprod, 16(9) (2001):2005-2007.

13. Van Oppenraaij, R.H., Jauniaux, E., Christiansen, O.B., et al. “Predicting adverse obstetric outcome after early pregnancy events and complications: a review.” Hum. Reprod. Update, 15(4) (2009):409-421.





DOI: http://dx.doi.org/10.18370/2309-4117.2014.20.56-60

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2411-1295 (Online), ISSN 2309-4117 (Print)